Practice guidelines are statements from professional bodies that help clinicians decide how to care for patients in specific situations. They include recommendations that are grounded in a systematic review of the available evidence and weigh the benefits and harms of different options. This approach aims to steer care toward what’s most effective and safe, while recognizing uncertainties and the values of patients. They aren’t laws or hospital bylaws, and they aren’t merely personal opinions. Instead, they guide practice and support decision-making, though clinicians still apply judgment and consider individual patient circumstances.

AANA practice guidelines are formal, evidence-based recommendations created by the American Association of Nurse Anesthesiology to guide everyday anesthesia care and protect patient safety. They translate research into concrete clinical practices that practitioners can apply at the bedside. Safe injection guidelines fit this purpose because they address the exact procedures used during anesthesia to administer drugs safely and prevent infection. They cover how to maintain aseptic technique, proper handling of vials, syringes, and needles, labeling, disposal, and preventing contamination or transmission of pathogens. This focus on the hands-on steps of medication administration in the perioperative setting is central to what AANA practice guidelines aim to standardize. In contrast, antibiotic stewardship guidelines are broad, system-wide guidance aimed at optimizing antimicrobial use across many settings and are typically issued by larger organizations or specialty groups beyond AANA. Pediatric anesthesia equipment standards rely on device specifications and regulatory or manufacturing standards rather than practice guidelines issued by AANA. Perioperative communication protocols, while important to safety, are often addressed by organizations focused on perioperative workflows or nursing practice rather than AANA’s anesthesia-specific clinical guidelines.

The essential idea is who has the authority to consent when a patient can’t make decisions. A healthcare power of attorney designates a specific agent to make medical choices for the patient, following the patient’s known wishes or acting in their best interests. This is a pre‑established arrangement that stays in effect if capacity is lost. If there is no healthcare POA, a surrogate decision maker steps in, and this person is chosen by statute or by the physician/hospital policy when no POA exists. The surrogate’s role is to guide decisions, often using substituted judgment or best interests standards, to obtain necessary consent for procedures like anesthesia. Both pathways provide authority to consent, but they come from different sources: a pre-designated agent via a healthcare POA versus a legally or policy-assigned surrogate when no POA is present. It’s not accurate to say surrogates must be court-appointed guardians, nor that a POA handles only financial decisions, nor that surrogates cannot consult with clinicians; surrogates commonly consult with clinicians to reach appropriate decisions.

Under HIPAA, PHI can be disclosed without patient authorization for treatment, payment, or healthcare operations, as long as safeguards are in place and the disclosure is limited to the minimum necessary information. This allows a provider to coordinate care with another clinician, bill a payer, or run essential business operations without a signed release. Marketing, on the other hand, generally requires patient authorization, so disclosure without authorization isn’t appropriate. The idea that PHI can be disclosed to any third party with facility approval is too broad and ignores required safeguards and the minimum-necessary rule. And saying PHI can never be disclosed without explicit authorization is false because TPO disclosures are allowed without authorization.